Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT02210169
Eligibility Criteria:
Inclusion Criteria:
\- Neonates in the neonatal unit with an infection requiring treatment with vancomycin as determined by the treating physician.
Exclusion Criteria:
* Infants with a corrected gestational age \< 25 weeks.
* Allergy to vancomycin or other glycopeptide antibiotic
* Vancomycin administered within the previous 72 hours
* Renal impairment
* Prior enrolment in the study
* Need for drug that is incompatible with vancomycin (if no other IV line is available)
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
90 Days
Study:
NCT02210169
Study Brief:
Protocol Section:
NCT02210169